Back
Innate Pharma SA Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
10
IPHA
Innate Pharma SA
Last Price:
1.50
Seasonality Move:
6.04%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Innate Pharma SA Stock Forecast
-
Is Innate Pharma SA Stock Undervalued?
The current Innate Pharma SA [IPHA] share price is $1.50. The Score for IPHA is 10, which is 80% below its historic median score of 50, and infers higher risk than normal. - IPHA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Innate Pharma SA Stock Go Up Next Year?
Data Unavailable
Innate Pharma SA Stock Rating
Data Unavailable
Innate Pharma SA Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
France
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
innate-pharma.com
52-Week Data
52-Week High:
3.15
52-Week Low:
1.29
Prediction Charts
Market Cap:
121.43M
Price in USD:
1.50
Volume:
9.41K
Beta:
0.36
Technical Analysis
SMA50:
1.94
SMA100:
2.08
SMA200:
2.29
52-Wk Change:
-38.02%
Stock Predictions
-
Is Innate Pharma SA stock public?
Yes, Innate Pharma SA is a publicly traded company. -
What is the Innate Pharma SA stock quote today?
The Innate Pharma SA stock price is 1.50 USD today. -
How to buy Innate Pharma SA stock online?
You can buy Innate Pharma SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-7 | 1.82 | 1.84 | 1.85 | 1.71 |
| Nov-8 | 1.57 | 1.84 | 1.87 | 1.57 |
| Nov-11 | 1.69 | 1.85 | 2.00 | 1.68 |
| Nov-12 | 1.75 | 1.90 | 1.91 | 1.75 |
| Nov-13 | 1.70 | 1.68 | 1.70 | 1.68 |
| Nov-14 | 1.65 | 1.67 | 1.68 | 1.62 |
| Nov-15 | 1.60 | 1.44 | 1.66 | 1.44 |
| Nov-18 | 1.45 | 1.53 | 1.66 | 1.29 |
| Nov-19 | 1.55 | 1.49 | 1.61 | 1.48 |
| Nov-20 | 1.60 | 1.69 | 1.70 | 1.60 |
| Nov-21 | 1.65 | 1.70 | 1.70 | 1.56 |
| Nov-22 | 1.60 | 1.63 | 1.70 | 1.54 |
| Nov-25 | 1.56 | 1.45 | 1.57 | 1.45 |
| Nov-26 | 1.48 | 1.50 | 1.50 | 1.48 |
Innate Pharma SA Earnings
Data Unavailable
Innate Pharma SA Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.